Huntington's chorea disease, a condition that affects the brain, is a complicated illness. It's caused by a glitch in our genes, leading to a breakdown in how the brain controls movement.
This article will explore the brain's role in this disease, how the genetic issue messes things up, and what we're learning about treating it.
Highlights
Huntington's chorea disease originates in the basal ganglia, a part of the brain responsible for smooth, controlled movements.
The brain has direct and indirect pathways that work together to balance starting and stopping movements.
A faulty gene causes an abnormal huntingtin protein, which is toxic to brain cells, particularly those in the indirect pathway.
Damage to the indirect pathway, often called the 'stop' pathway, leads to uncontrolled, jerky movements characteristic of chorea.
Dopamine, a brain chemical, can worsen these excess movements when the indirect pathway is compromised.
The disease typically appears in adulthood because it takes time for the toxic protein to build up and damage enough brain cells.
While chorea is a hallmark, Huntington's disease also affects thinking and emotions, leading to a wide range of symptoms.
Current treatments aim to manage symptoms, like chorea, by rebalancing brain chemicals, but research continues for ways to slow or stop the disease itself.
Where Does Huntington’s Chorea Originate in the Brain?
What Is the Basal Ganglia's Role in Movement Control?
The brain is a complex organ, and when it comes to controlling our movements, a specific set of structures called the basal ganglia plays a starring role.
Think of the basal ganglia as the brain's sophisticated command center for everything from taking a simple step to performing a complex dance. These structures are deep within the brain and are made up of several interconnected nuclei.
They don't directly send signals to our muscles, but they act as crucial intermediaries, refining and coordinating the motor commands that originate elsewhere.
How Do Direct and Indirect Pathways Balance Movement?
Within the basal ganglia, movement control is managed through intricate circuits. Two main pathways, often referred to as the direct and indirect pathways, work in opposition to fine-tune our actions.
The direct pathway generally facilitates movement, essentially telling the body to 'go'. Conversely, the indirect pathway acts as a brake, inhibiting unwanted movements and helping to maintain smooth, controlled motion.
This delicate balance between excitation and inhibition is absolutely vital for fluid and purposeful movement. When this system is disrupted, as seen in brain conditions like Huntington's chorea, the result can be uncontrolled and involuntary movements.
How the Huntingtin Mutation Disrupts Movement Control
Why Is the Indirect 'Stop' Pathway Selectively Vulnerable?
In Huntington's disease, the genetic mutation in the huntingtin gene leads to a faulty huntingtin protein. This abnormal protein is particularly toxic to specific types of neurons within the basal ganglia.
Neuroscience research indicates that the neurons forming the indirect pathway are disproportionately affected. These neurons are more sensitive to the damage caused by the mutant huntingtin protein, leading to their dysfunction and eventual death.
How Does a Damaged Indirect Pathway Lead to Excess Movement?
When the indirect pathway, the brain's 'stop' system, is damaged in Huntington's disease, its ability to suppress unwanted movements is significantly impaired. With the 'brakes' weakened, there's a loss of inhibition over the thalamus.
This disinhibition allows for excessive signaling to the motor cortex, resulting in involuntary, jerky, and excessive movements characteristic of chorea. It's like the body's natural control mechanisms for stopping or slowing down movements are no longer functioning effectively.
What Role Does Dopamine Play in Magnifying Chorea?
Dopamine, a neurotransmitter involved in movement, reward, and other functions, plays a complex role in Huntington's disease. While the exact mechanisms are still being studied, it's understood that dopamine can exacerbate the effects of the damaged indirect pathway.
In the context of a weakened 'stop' signal, dopamine can further amplify the excitatory signals, leading to a more pronounced and severe presentation of chorea. This interaction highlights how different neurochemical systems can interact to produce the observable symptoms of the disease.
How Does Cellular Damage Progress to Visible Symptoms?
How Mutant Huntingtin Protein Causes Neuronal Dysfunction?
The root of Huntington's disease lies in a specific genetic change, a mutation in the huntingtin gene. This mutation causes the body to produce an altered huntingtin protein.
Instead of folding correctly, this faulty protein tends to clump up inside brain cells. These protein clumps are not harmless; they actively damage and can eventually destroy neurons, particularly those in the basal ganglia that are vital for controlling movement.
This cellular damage disrupts the normal communication pathways within the brain, leading to the characteristic symptoms of the disease.
Why Does Chorea Appear in Mid-Life and Not Earlier?
While the genetic mutation is present from birth, the symptoms of Huntington's disease, including chorea, typically don't manifest until adulthood, usually between the ages of 30 and 50.
This delay is thought to be due to a few factors. Firstly, the brain has a remarkable capacity for compensation. For years, healthy neurons can work harder to make up for the damage caused by the mutant protein.
Secondly, the accumulation of toxic protein clumps and the resulting neuronal dysfunction is a gradual process. It takes time for enough damage to occur in critical brain areas before the symptoms become noticeable.
The exact mechanisms triggering this "late onset" are still an area of active research.
Why Might Chorea Decrease in Late-Stage Huntington's?
It might seem counterintuitive, but the involuntary, jerky movements of chorea can sometimes lessen or even disappear in the very late stages of Huntington's disease.
This isn't a sign of improvement. Instead, it reflects the widespread and severe degeneration of brain cells. As more and more neurons in the motor control pathways are destroyed, the brain loses its capacity to generate the excessive, uncontrolled movements characteristic of chorea.
In these advanced stages, people may instead experience rigidity and a significant reduction in all movement, a state known as akinesia, rather than the earlier, more prominent choreiform movements.
How Does Electrophysiology Reveal Functional Brain Disruption?
How Is EEG Used to Measure Cortical Hyperexcitability?
While cellular models and structural imaging reveal the physical deterioration of the basal ganglia, electroencephalography (EEG) provides researchers with a real-time window into the resulting electrical chaos.
In Huntington's disease, the degradation of the indirect "stop" pathway means the cerebral cortex is no longer receiving appropriate inhibitory signals. Using EEG, scientists can measure this functional consequence directly by observing signs of cortical hyperexcitability.
The recordings often show a brain that is electrically overactive, lacking the normal physiological dampening required to suppress unwanted, spontaneous involuntary movements like chorea. This provides a measurable, large-scale functional signature that bridges the gap between cellular pathology and visible symptoms.
How Do Researchers Track Changes in Brain Networks and Connectivity?
Beyond measuring overall cortical excitability, researchers utilize EEG to track how communication between distinct regions of the brain becomes dysregulated.
The brain relies on synchronized electrical oscillations to transfer information efficiently across different neural networks. In people with Huntington's disease, functional EEG analysis demonstrates that these delicate signaling networks frequently fall out of sync.
By mapping these altered connectivity patterns, researchers can visualize how the disease's physical impact radiates outward from the basal ganglia, disrupting large-scale cortical communication and contributing to both the complex motor symptoms and the cognitive changes associated with the condition.
What Is the Potential Impact of EEG Biomarkers for Future Research?
Because EEG provides a direct, non-invasive measure of neural function, scientists are actively investigating its potential to yield reliable biomarkers for Huntington's disease.
The scientific goal is to identify specific, quantifiable electrical signatures that consistently correlate with the progression of chorea or neural decline. If validated, these objective EEG biomarkers could be utilized in clinical trials to measure whether an experimental neuroprotective drug or gene therapy is successfully stabilizing the brain's functional activity before visible physical symptoms change.
However, it is crucial to recognize that this remains an active, ongoing area of investigation; currently, EEG is utilized primarily to study the mechanisms of Huntington's disease in research settings rather than serving as a standard diagnostic or monitoring tool in routine clinical practice.
How Do Targeted Treatments for Chorea Work?
While there isn't a cure for Huntington's disease yet, medical science has made progress in managing its symptoms, particularly the involuntary movements known as chorea.
The focus is on understanding how the faulty huntingtin protein disrupts brain pathways and then finding ways to rebalance those systems.
How Do VMAT2 Inhibitors Rebalance the Dopamine System?
One approach involves medications that target the way dopamine, a key chemical messenger in the brain, is handled. Dopamine plays a role in movement, but too much of it, or an imbalance in its signaling, can worsen chorea in Huntington's disease.
This is where drugs like tetrabenazine and deutetrabenazine come into play. They work by affecting a protein called vesicular monoamine transporter 2 (VMAT2).
VMAT2's Role: This protein is found in the brain and helps package neurotransmitters, like dopamine, into vesicles for storage and release. Think of it like a loading dock for these chemical messengers.
Inhibiting VMAT2: By inhibiting VMAT2, these medications reduce the amount of dopamine that is released into the brain's signaling pathways. This doesn't eliminate dopamine, but it helps to dial down its activity, which can lessen the excessive movements associated with chorea.
Rebalancing Act: The goal is to restore a more balanced level of dopamine signaling, thereby reducing the overactivity in the brain circuits that leads to choreiform movements. It's a way to gently turn down the volume on certain neural signals that have become too loud due to the disease.
What Are the Current Research Directions Beyond Symptom Management?
Beyond managing chorea, research is pushing forward to address the root causes of Huntington's disease and explore other treatment strategies. The ultimate aim is to slow or stop the progression of the disease itself, not just its outward signs.
Gene Silencing: Some promising research involves trying to reduce the production of the toxic huntingtin protein. Techniques like gene silencing aim to interfere with the genetic instructions that lead to the faulty protein's creation.
Neuroprotection: Another area of focus is protecting the neurons that are vulnerable to damage in Huntington's disease. Researchers are investigating compounds that could shield these brain cells from the toxic effects of the mutant huntingtin protein.
Restoring Pathway Function: Efforts are also underway to find ways to repair or restore the function of the disrupted direct and indirect pathways in the basal ganglia. This could involve therapies that help the brain circuits work more efficiently again.
Clinical Trials: Many of these innovative approaches are being tested in clinical trials. Participating in these studies, when appropriate, can offer access to cutting-edge treatments and contribute to a greater understanding of Huntington's disease for future generations.
What Does the Future Hold for Huntington's Disease Research?
So, Huntington's disease is a tough one, no doubt about it. It's caused by a glitch in our genes, specifically a part of chromosome 4 that repeats too many times. This leads to a faulty protein that messes with brain cells, causing those jerky movements, thinking problems, and mood swings we've talked about.
While there's no cure yet, and it's inherited in a way that means if a parent has it, there's a 50/50 chance their kid will too, there's still hope. Researchers are working hard on new treatments, and doctors can help manage the symptoms to make life better for those affected and their families.
It's a complex disease, but understanding the genetic root is a big step in finding ways to help.
References
Bunner, K. D., & Rebec, G. V. (2016). Corticostriatal Dysfunction in Huntington's Disease: The Basics. Frontiers in human neuroscience, 10, 317. https://doi.org/10.3389/fnhum.2016.00317
Piano, C., Mazzucchi, E., Bentivoglio, A. R., Losurdo, A., Calandra Buonaura, G., Imperatori, C., ... & Della Marca, G. (2017). Wake and sleep EEG in patients with Huntington disease: an eLORETA study and review of the literature. Clinical EEG and neuroscience, 48(1), 60-71. https://doi.org/10.1177/1550059416632413
Ponomareva, N. V., Klyushnikov, S. A., Abramycheva, N., Konovalov, R. N., Krotenkova, M., Kolesnikova, E., ... & Illarioshkin, S. N. (2023). Neurophysiological hallmarks of Huntington’s disease progression: An EEG and fMRI connectivity study. Frontiers in aging neuroscience, 15, 1270226. https://doi.org/10.3389/fnagi.2023.1270226
Frequently Asked Questions
What does 'chorea' mean in Huntington's chorea?
The word 'chorea' comes from a Greek word that means 'dance.' It's used because one of the main symptoms is involuntary, jerky, or writhing movements that can look a bit like dancing. These movements are not controlled by the person.
How does the gene change lead to uncontrolled movements?
The faulty huntingtin protein damages specific pathways in the basal ganglia that help control movement. One important pathway, often called the 'stop' pathway, gets weakened. When this pathway can't effectively tell the body to stop moving, it results in the excessive, uncontrolled movements seen in chorea.
What are the first signs of Huntington's disease?
Often, the first signs aren't obvious movement problems. People might notice changes in their mood, like becoming more irritable or depressed, or have trouble concentrating or making decisions. Sometimes, subtle jerky movements in the hands or face are the first physical signs.
At what age do symptoms of Huntington's disease usually start?
Symptoms typically begin to appear when people are between 30 and 50 years old. However, in some cases, especially a form called juvenile Huntington's disease, symptoms can start much earlier, even before age 20.
Why do symptoms appear in mid-life and not earlier?
The brain damage from the faulty huntingtin protein happens gradually over many years. It takes time for enough brain cells to be affected before noticeable symptoms begin to show up, usually in adulthood.
Emotiv is a neurotechnology leader helping advance neuroscience research through accessible EEG and brain data tools.
Emotiv
